Cite
HARVARD Citation
Moyle, G. et al. (2013). 96-Week Results of Abacavir/Lamivudine versus Tenofovir/Emtricitabine, plus Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: Assert Study. Antiviral therapy. 18 (7), pp. 905-913. [Online].